Green Dae

WEEK IN REVIEW: Cannabis and CBD Highlights
December 30, 2024 - January 3, 2025

January 3, 2025: Canada Launches First Cannabis-Infused Alcohol Alternatives
Event: Cannabis Drinks Industry Expands with Alcohol-Free Spirits
Details: Greenstream, Canada’s first cannabis-infused alcohol alternative brand, launched its flagship line of beverages. These THC- and CBD-infused products mimic the flavors of traditional spirits, offering consumers a hangover-free social drinking option. Early consumer reviews highlight their refreshing taste and consistent dosing, appealing to both cannabis enthusiasts and those seeking alternatives to alcohol. Industry experts believe cannabis beverages will capture a significant share of Canada’s $3 billion recreational cannabis market within the next decade.

WEEK IN REVIEW: Cannabis and CBD Highlights
December 30, 2024 - January 3, 2025

January 2, 2025: Israel Debates Full Cannabis Legalization

Event: Israeli Parliament Considers Comprehensive Cannabis Reform Bill
Details: The Israeli Knesset opened debates on a bill to legalize and regulate recreational cannabis. The proposed law includes provisions for home cultivation, licensed dispensaries, and strict penalties for illegal distribution. Advocates highlight the potential to generate $500 million annually in tax revenue while reducing law enforcement costs. Opponents cite public health concerns and the risk of youth access. If passed, Israel would become one of the few Middle Eastern nations to adopt full cannabis legalization, further solidifying its leadership in global cannabis innovation.

WEEK IN REVIEW: Cannabis and CBD Highlights
December 30, 2024 - January 3, 2025

December 31, 2024: Mexico Hosts New Year’s Cannabis Festival

Event: Mexico Rings in 2025 with Its First Cannabis Cultural Celebration
Details: Mexico City hosted a historic New Year’s Eve cannabis festival, combining cultural events, music, and educational workshops. Organized in collaboration with local cannabis advocates and government agencies, the festival featured legal cannabis product displays, food trucks serving hemp-infused delicacies, and wellness booths offering CBD-based treatments. The event is seen as a turning point for cannabis normalization in Mexico, attracting thousands of attendees and sparking discussions about the future of public cannabis events in the country.

WEEK IN REVIEW: Cannabis and CBD Highlights
December 30, 2024 - January 3, 2025

December 30, 2024: France Legalizes Recreational Cannabis Sales

Event: France Becomes the Latest European Country to Legalize Cannabis
Details: France has officially legalized the sale of recreational cannabis, making it the third EU country to do so after Germany and Malta. Under the new legislation, adults aged 21 and over can purchase cannabis from licensed dispensaries. Strict rules on advertising, product labeling, and maximum THC limits have been implemented to ensure public safety. The government anticipates €3 billion in annual tax revenue, with a portion earmarked for public health initiatives and drug education programs. Critics warn of potential enforcement challenges and the risk of insufficient supply during the market’s launch phase.

ALL CBD PRODUCTS ARE JUST $10—while supplies last! Don't miss this chance to stock up on your favorite CBD essentials at an unbeatable price. 🌱

📦 Shop now and elevate your wellness routine!

🛒 Shop at Green Dae Today
📅 Limited Time Only | ⏳ While Supplies Last


www.greendae.com

WEEK IN REVIEW: Cannabis and CBD Highlights

December 9, 2024: Germany Prepares for Adult-Use Cannabis Market Launch
Event: Germany Sets 2025 as Target for Recreational Market Rollout
Details: Following its groundbreaking legalization earlier this year, Germany is finalizing regulations to launch its adult-use cannabis market in early 2025. The framework includes a centralized licensing system, environmental standards for cultivation, and restrictions on advertising to prevent youth appeal. Industry insiders estimate that the German cannabis market could generate up to €5 billion annually. However, critics worry about the potential for a slow rollout and high taxes limiting competition with the black market.

WEEK IN REVIEW: Cannabis and CBD Highlights

December 6, 2024: U.S. Congress Introduces Federal Cannabis Banking Reform Bill
Event: Lawmakers Push for Cannabis Banking Access
Details: A bipartisan group of lawmakers has introduced a bill to provide cannabis businesses access to banking services, addressing one of the industry's most significant challenges. If passed, the legislation would allow cannabis companies to open bank accounts and secure loans without fear of federal penalties. Advocates argue that the reform is long overdue and critical for the industry's growth, while opponents caution against federal normalization of cannabis.

WEEK IN REVIEW: Cannabis and CBD Highlights

December 5, 2024: Singapore Conducts First Cannabis Research Trials
Event: Singapore Launches Medical Cannabis Research
Details: Known for its strict drug laws, Singapore has surprised the global community by initiating its first-ever clinical trials on cannabis-derived treatments. These trials, conducted under stringent conditions, aim to explore the efficacy of CBD for treating severe epilepsy and chronic pain. While recreational cannabis remains strictly prohibited, this development is seen as a cautious yet significant step in advancing medical cannabis research in Asia.

WEEK IN REVIEW: Cannabis and CBD Highlights

December 4, 2024: South Africa Increases Cannabis Cultivation Licenses
Event: South Africa Grants 100 New Cannabis Licenses
Details: The South African government has issued 100 new cannabis cultivation licenses aimed at boosting the country's emerging cannabis economy. These licenses focus on small-scale farmers and rural communities, emphasizing social equity and economic inclusion. With international markets eyeing African cannabis as the next big opportunity, South Africa's strategic focus on high-quality exports could position it as a global leader in the industry.

WEEK IN REVIEW: Cannabis and CBD Highlights

December 3, 2024: France Launches First Medical Cannabis Distribution Centers
Event: France Opens Public Access to Medical Cannabis
Details: France has launched its first state-sponsored medical cannabis distribution centers, providing free access to patients with prescriptions. This pilot program, part of France's cautious approach to cannabis reform, is expected to serve thousands of patients suffering from chronic pain, epilepsy, and chemotherapy-related side effects. Advocacy groups are pushing for expanded eligibility criteria and more streamlined access, signaling a potential shift toward broader acceptance of cannabis-based treatments.

WEEK IN REVIEW: Cannabis and CBD Highlights

December 2, 2024: Mexico Approves Cannabis Export Regulations
Event: Mexico Greenlights Cannabis Export Rules
Details: Mexico's government has approved new regulations allowing licensed cannabis producers to export their products internationally. This move positions Mexico as a key player in the global cannabis trade, particularly in medical cannabis and hemp-derived CBD. Industry experts predict that this development could attract foreign investment and help stabilize the domestic market. However, critics argue that the lack of clear guidelines for domestic legalization leaves local producers at a disadvantage.

WEEK IN REVIEW: Cannabis and CBD Highlights

November 28, 2024: Australia’s Medicinal Cannabis Program Expands
Event: Australia Approves New Cannabis-Based Medications
Details: Australia’s Therapeutic Goods Administration has approved two new cannabis-derived medications for chronic pain and epilepsy. This expansion reflects growing acceptance of cannabis-based treatments in the country’s healthcare system. Patients and advocates are celebrating the decision, which is expected to increase access to safe and effective medicinal cannabis products for thousands of Australians.